The BD Liverty™ TIPS Stent Graft Study
NCT05711316 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 177
Last updated 2026-07-20
Summary
The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).
Conditions
- Portal Hypertension
- TIPS
Interventions
- DEVICE
-
BD Liverty™ TIPS Stent Graft
Treatment of portal hypertension complications with placement of the BD Liverty™ TIPS Stent Graft after creation of a Transjugular Intrahepatic Portosystemic Shunt.
Sponsors & Collaborators
-
C. R. Bard
lead INDUSTRY
Principal Investigators
-
Ziv Haskal, M.D. · University of Virginia
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-08
- Primary Completion
- 2025-06-23
- Completion
- 2027-01-11
- FDA Device
- Yes
Countries
- United States
- France
- Germany
Study Locations
More Related Trials
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05010161 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT00597571 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05741463 ·Status: WITHHELD
-
Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD
NCT07116109 ·Status: RECRUITING ·Phase: NA
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT03748316 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT07221136 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT00578513 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05479162 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05573061 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05750069 ·Status: WITHHELD
-
Closed-loop TMS for the Core Clinical Features of the Methamphetamine Use Disorder
NCT07154160 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT02576210 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT01311726 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05270811 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT01367171 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT00957138 ·Status: WITHHELD
-
A Study of Belotero® Intense Lidocaine for Lip Augmentation
NCT05773066 ·Status: COMPLETED ·Phase: NA
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT02911376 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05177315 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05714709 ·Status: WITHHELD
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT00725816 ·Status: WITHHELD
-
Mobile Technology to Reduce Teen Substance Misuse
NCT05897164 ·Status: RECRUITING ·Phase: NA
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05759559 ·Status: WITHHELD
-
Remote Monitoring of Vital Signs With Telehealth to Prevent Readmissions for Dysglycemia
NCT05746286 ·Status: COMPLETED ·Phase: NA
-
[Trial of device that is not approved or cleared by the U.S. FDA]
NCT05796414 ·Status: WITHHELD